Syra Health Corp. (SYRA)
NASDAQ: SYRA · Real-Time Price · USD
0.374
+0.009 (2.32%)
Nov 21, 2024, 2:27 PM EST - Market open

Syra Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
7.745.525.621.41-
Revenue Growth (YoY)
35.47%-1.83%298.43%--
Cost of Revenue
5.974.114.590.98-
Gross Profit
1.781.411.030.43-
Selling, General & Admin
5.134.013.110.430.05
Research & Development
0.830.24---
Operating Expenses
6.034.33.120.430.05
Operating Income
-4.25-2.89-2.09-0-0.05
Interest Expense
-0.02-0.05-0.03--
Interest & Investment Income
0.0200--
Pretax Income
-4.25-2.94-2.12-0-0.05
Net Income
-4.25-2.94-2.12-0-0.05
Net Income to Common
-4.25-2.94-2.12-0-0.05
Shares Outstanding (Basic)
753114
Shares Outstanding (Diluted)
753114
Shares Change (YoY)
46.18%60.40%264.93%-93.94%-
EPS (Basic)
-0.64-0.60-0.70-0.00-
EPS (Diluted)
-0.64-0.60-0.70-0.00-
Free Cash Flow
-4.49-2.77-2.37-0.09-
Free Cash Flow Per Share
-0.67-0.57-0.78-0.11-
Gross Margin
22.94%25.54%18.35%30.52%-
Operating Margin
-54.89%-52.36%-37.20%-0.23%-
Profit Margin
-54.90%-53.28%-37.71%-0.23%-
Free Cash Flow Margin
-57.94%-50.30%-42.10%-6.70%-
EBITDA
-4.18-2.84-2.07-0-
EBITDA Margin
-54.02%-51.48%-36.93%-0.22%-
D&A For EBITDA
0.070.050.010-
EBIT
-4.25-2.89-2.09-0-0.05
EBIT Margin
-54.89%-52.36%-37.20%-0.23%-
Revenue as Reported
---1.41-
Source: S&P Capital IQ. Standard template. Financial Sources.